• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Life Science seminar

Emilie Håkonsson LohseSoMe & Communication Coordinator
31.08.2023, 08.45

Do you want to know more about the latest development in the Nordic Life Science industry? Get an update on HC Andersen Capital's view on valuation as well as presentations from listed Life Science companies focussing on their late-stage pipeline.

We have the pleasure of welcoming Bavarian Nordic, Gubra, ExpreS2ion Biotechnologies, Ascelia Pharma, Pharma Equity Group, Curasight, Hansa Biopharma, Qlife, Index Pharmaceuticals, NeoDynamics and BioPorto.

You can find the agenda for the seminar here.

Disclaimer: HC Andersen Capital receives payment from the attending companies for a Digital IR/corporate visibility agreement.

Stay up to date
Bavarian Nordic
Gubra
ExpreS2ion Biotech
Ascelia Pharma
Pharma Equity Group
Curasight
BioPorto
Hansa Biopharma
Qlife Holding
Flerie
NeoDynamics

Upcoming webcasts

Recent videos

HCA Morgenbørs 04/08 - Positiv åbning på forventninger om en nedtrapning af konflikten i Iran
04.08.2026, 09.16 Novo Nordisk
Asmodee, Audiocast, Q1'26
04.08.2026, 09.00 Asmodee
Aspo Oyj, Webcast, Q2'26
03.08.2026, 11.00 Aspo
HCA Morgenbørs 03/08 - Prisfald i olie driver positivt marked
03.08.2026, 09.28 Novo Nordisk
Outokumpu, Webcast, Q2'26
30.07.2026, 13.30 Outokumpu
View all videos